Dociparstat

Drug identity checked against registry records

Also recorded as 2-0,3-0 desulfated heparin; CX-01; DSTAT; ODSH; dociparstat sodium

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Dociparstat in Combination With Standard Chemotherapy for the Treatment of Acute Myeloid LeukemiaNCT04571645Jazz PharmaceuticalsPhase 3Terminated2022-05-16Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.